Cancer Misinformation Pervasive Among Newly Diagnosed Patients, UF Study Finds
A groundbreaking study conducted by the UF Health Cancer Center reveals a startlingly high prevalence of cancer misinformation among newly diagnosed patients. An overwhelming 93% of participants reported exposure to at least one form of misinformation concerning cancer treatments, highlighting a critical challenge in ensuring patients receive accurate and evidence-based care. This misinformation, encompassing unproven or debunked treatments, myths, and misconceptions, permeates the patient experience, often reaching them unsolicited and influencing their understanding of their disease and treatment options. The study’s findings underscore the urgent need for healthcare providers to proactively address this issue and equip patients with reliable information to navigate their cancer journey.
The study, published in the Journal of Cancer Education, emphasizes the pervasiveness of misinformation even among patients who aren’t actively seeking alternative therapies. Lead author Naomi Parker, Ph.D., an assistant scientist in the UF Department of Health Outcomes and Biomedical Informatics, points to the pervasive nature of online algorithms and social networks as key contributors. Upon receiving a diagnosis, patients become susceptible to a deluge of information, both solicited and unsolicited, from friends, family, and social media platforms. This can lead to exposure to unproven remedies, such as the misconception that vitamin C can cure cancer, even if the patient wasn’t initially looking for such information. This passive exposure highlights the insidious nature of misinformation and the challenges in shielding patients from inaccurate and potentially harmful claims.
The pervasiveness of misinformation poses a significant threat to effective cancer care. Exposure to unproven treatments can lead patients to delay or forgo evidence-based therapies, jeopardizing their chances of successful outcomes. Furthermore, misinformation can erode trust between patients and their oncologists, creating communication barriers and hindering the development of strong therapeutic relationships. The emotional vulnerability that accompanies a cancer diagnosis makes patients more susceptible to misinformation, as they grapple with fear, anxiety, and an overwhelming amount of new information to process. This vulnerability underscores the importance of providing clear, accurate, and empathetic guidance from healthcare professionals.
The study’s findings represent a significant shift in misinformation research, previously focused on analyzing the content of platforms like TikTok. This research, however, directly examines patient experiences, revealing the interpersonal nature of misinformation dissemination. Senior author Carma Bylund, Ph.D., professor and associate chair of education in the UF Department of Health Outcomes and Biomedical Informatics, notes that while the internet remains a primary source, misinformation often reaches patients through well-meaning friends and family. This interpersonal transmission adds a layer of complexity to the issue, requiring healthcare providers to not only educate patients but also equip them to critically evaluate information shared by their loved ones.
The research team developed a comprehensive survey to assess patients’ exposure to misinformation, focusing on five categories of unproven treatments: vitamins and minerals, herbs and supplements, special diets, mind-body interventions, and miscellaneous treatments, along with common cancer myths and misconceptions. The survey was administered to 110 UF Health patients diagnosed with prostate, breast, colorectal, or lung cancer within the past six months, a crucial period for initial treatment decisions. The results revealed that most patients had heard of potential cancer treatments beyond the standard of care, and a majority reported exposure to at least one myth or misconception. Close friends and family, websites, distant relatives or acquaintances, social media, and news media were identified as the most common sources of misinformation.
The study’s implications for the doctor-patient relationship are profound. Bylund emphasizes the need for clinicians to proactively assume that patients have been exposed to misinformation, regardless of whether they actively sought it out. This proactive approach allows physicians to address misinformation directly, provide evidence-based information, and strengthen the patient-physician bond. The study also found that patients rarely discussed the alternative treatments they encountered with their oncologists, highlighting a missed opportunity for education and clarification. This underscores the need for open communication and a safe space for patients to discuss any information they encounter, regardless of its source.
Looking ahead, the research team plans to expand the study to a larger and more diverse patient population, further exploring the impact of misinformation on treatment decisions and outcomes. They are also piloting an “information prescription” program, partnering with oncologists to guide patients towards reputable resources like the American Cancer Society. This innovative approach aims to empower patients with the tools to critically evaluate health information and make informed decisions based on evidence-based medicine. This initiative, along with other similar strategies under development, represents a crucial step in combating the spread of misinformation and ensuring that cancer patients receive the best possible care.